Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 15:11:39 16/07/2024 BST 		5-day change 1st Jan Change
0.923 EUR +0.33% Intraday chart for Lavipharm S.A. +5.73% +15.95%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Generic Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LAVIPHARM S.A. Stock Lavipharm S.A.
 169M - - - - -
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
 45.54B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
 24.51B
SANDOZ GROUP AG Stock Sandoz Group AG
 16.48B
CIPLA LIMITED Stock Cipla Limited
 14.66B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
 14.3B
  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. Charts Lavipharm S.A.
  5. Sector Chart